Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDialight Regulatory News (DIA)

Share Price Information for Dialight (DIA)

Share Price is delayed by 15 minutes
Get Live Data
381.00    8.00 (2.14%)
Bid:
379.00
Ask:
400.00
Spread: 21.00 (5.541%)
Market Cap: £152.30m
DIA Live PriceLast checked at - London Stock Exchange

Intraday Dialight Share Chart

Trading Statement

28 Jan 2025 07:00

RNS Number : 8663U
Dialight PLC
28 January 2025
 

FOR IMMEDIATE RELEASE

 

Dialight PLC

28 January 2025

 

Dialight plc ("Dialight" or the "Company")

Q3 trading update

&

Sanmina litigation - settlement discussions

 

Q3 trading update

Trading performance for the 3-month period ended 31 December 2024 was slightly ahead of our expectations. The business traded profitably and generated positive operating cash flow. Group net debt (excluding leases) at 31 December 2024 was $14.8m (30 September 2024: $15.4m). The Board remains confident that further progress will be made during the rest of the financial year.

 

The early Transformation Plan progress reported with the Interim Results in November continued to gain momentum in the third quarter which has allowed us to introduce our 5th Transformation Pillar of creating a platform for future growth. This will provide a strategy and innovation platform for future products and services that, together with the other four pillars, will provide a solid sales and operational base for future, profitable growth. We will also continue to explore opportunities to accelerate our Transformation Plan to focus on delivering our medium-term ambitions.

 

Sanmina litigation - settlement discussions

On 25 September 2024, Dialight announced the details of the jury verdict in the trial relating to the litigation with its former manufacturing partner, Sanmina Corporation (NASDAQ: SANM) (Sanmina) and confirmed that a definitive judgment would be handed down once certain post-trial motions had been filed. Those post-trial motions have now been filed.

 

The Company is pleased to announce that, following constructive discussions with Sanmina, agreement has now been reached in principle to resolve the dispute. Under the settlement terms, Dialight will pay Sanmina $12m in full and final settlement of all claims between the parties. This amount will be paid in instalments, with the first payment of $4m due by 31 March 2025, followed by 8 instalments (the Deferred Instalments) of $1m paid at the end of each subsequent calendar quarter through to 31 March 2027.

 

The amount of any outstanding Deferred Instalments will be automatically increased from $1m to $1.5m if Dialight's market capitalisation exceeds £100m for 30 consecutive days, subject to total cumulative instalment payments not exceeding $8m. A letter has been filed with the New York Southern District court requesting that judgment is deferred pending agreement on a final definitive settlement and the parties will work together to agree a final definitive settlement agreement.

 

The Board is confident that the initial payment of $4m and the Deferred Instalments totalling $8m will be met from the operational cashflow of the business and that the Group has sufficient headroom to meet its ongoing business needs. In the highly remote event of payment default under the settlement agreement following the initial payment, Sanmina will be entitled to enforce the full judgment (less payments already made) in the ordinary course following a 90-day cure period (1).

 

Steve Blair, Dialight CEO, commented: "I am pleased that we have been able to reach a settlement that allows us to put this long running issue behind us. I would particularly like to thank Jure Sola and Jon Faust of Sanmina for their openness and willingness to agree the settlement. Our focus remains on our Transformation Plan for Dialight, for the benefit of all our stakeholders."

 

Note 1: The full judgment, equating to the total claims by Sanmina (as previously disclosed), would amount to $22.9m comprising the jury award of $8.6m, interest of $6.3m and legal costs of $7m.

 

Contacts: 

 

Dialight plc

Tel: +44 (0)203 058 3542

Steve Blair, CEO

Mark Fryer, CFO

 

Investec Bank plc (Financial Adviser and Corporate Broker)

Tel: +44 (0)207 597 5970

Christopher Baird / James Rudd

 

 

Dialight plc

 

About Dialight:

Dialight (LSE: DIA.L) is a global leader in sustainable LED lighting for industrial applications. Dialight's LED products are providing the next generation of lighting solutions that deliver reduced energy consumption and create a safer working environment. Our products are specifically designed to provide superior operational performance, reliability and durability, reducing energy consumption and ongoing maintenance and achieving a rapid return on investment. The company is headquartered in the UK with operations in Australia, Dubai, Germany, Malaysia, Mexico, Singapore, the UK and the USA. www.dialight.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAFFXALNSEAA
Date   Source Headline
17th Apr 20237:00 amRNSDirector/PDMR Shareholding
14th Apr 20231:03 pmRNSDirector/PDMR Shareholding
12th Apr 202312:30 pmRNSNotice of AGM
6th Apr 20232:35 pmRNSTotal Voting Rights
6th Apr 20232:20 pmRNSDirector/PDMR Shareholding
5th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20231:03 pmRNSBlock listing Interim Review
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20237:00 amRNSDirectorate Change
27th Mar 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSDirectorate Change
15th Mar 20235:14 pmRNSDirector Declaration
15th Mar 20237:00 amRNSSanmina Litigation
13th Jan 20237:00 amRNSDirectorate Change
13th Jan 20237:00 amRNSTrading Statement
5th Jan 20234:40 pmRNSSecond Price Monitoring Extn
5th Jan 20234:35 pmRNSPrice Monitoring Extension
14th Dec 202212:49 pmRNSDirectorate Change
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSTrading Statement
26th Oct 20227:00 amRNSDirectorate Change
11th Oct 20222:26 pmRNSHolding(s) in Company
3rd Oct 20225:50 pmRNSBlock listing Interim Review
1st Aug 20227:00 amRNSHalf-year Report
5th Jul 20221:46 pmRNSHolding(s) in Company
15th Jun 20227:00 amRNSAppointment of Corporate Broker
6th Jun 20227:00 amRNSDirector/PDMR Shareholding
24th May 20224:40 pmRNSSecond Price Monitoring Extn
24th May 20224:36 pmRNSPrice Monitoring Extension
23rd May 20224:41 pmRNSSecond Price Monitoring Extn
23rd May 20224:35 pmRNSPrice Monitoring Extension
19th May 202212:51 pmRNSResult of AGM
19th May 20227:00 amRNSTrading Statement
16th May 20224:23 pmRNSHolding(s) in Company
11th May 202211:07 amRNSHolding(s) in Company
5th May 20227:25 amRNSSmaller related party transaction & voting rights
4th May 20223:58 pmRNSHolding(s) in Company
3rd May 20223:11 pmRNSTotal Voting Rights
25th Apr 20224:34 pmRNSAdditional Listing
22nd Apr 20224:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:36 pmRNSPrice Monitoring Extension
14th Apr 20221:55 pmRNSNotice of AGM
14th Apr 202210:44 amRNSDirector/PDMR Shareholding
13th Apr 20224:40 pmRNSSecond Price Monitoring Extn
13th Apr 20224:35 pmRNSPrice Monitoring Extension
12th Apr 20225:27 pmRNSDirector/PDMR Shareholding
6th Apr 20229:58 amRNSDirector/PDMR Shareholding
6th Apr 20229:53 amRNSDirector/PDMR Shareholding
5th Apr 20223:07 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.